US 12378201
Histone demethylase inhibitors for treating cancers
granted A61KA61K31/47A61P
Quick answer
US patent 12378201 (Histone demethylase inhibitors for treating cancers) held by The Board of Regents of the University of Texas System expires Mon Jul 31 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Aug 05 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 31 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K31/47, A61P, A61P35/00